Indonesia's Kalbe Farma has high-tech ambitions

20161024_Kalbe_tablets2

A worker shows off pills produced at a Kalbe Farma plant in Cikarang, on the outskirts of Jakarta.

ERWIDA MAULIA, Nikkei staff writer

JAKARTA Indonesia's largest pharmaceutical company, Kalbe Farma, is transforming itself from a maker of generic drugs to a high-tech pharma developer. Its two-year-old cancer drug plant has begun reaping results, and Kalbe is stepping up research and development of stem cell therapy products.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.